From: alice bell <abell@pppgh.org>
Date: Thu, May 3, 2012 at 12:34 PM
Subject: [NOPE_WG] FW: Naloxone shortages
To: NOPE_WG@googlegroups.com
For anyone who is directly experiencing naloxone shortages, the FDA would like to hear about them directly. See below for link to webpage for reporting.
Alice Bell, L.C.S.W.
Overdose Prevention Project Coordinator
Prevention Point Pittsburgh
907 West Street, 5th Floor
Pittsburgh, PA 15221
From: Hunter, James R [mailto:James.Hunter@fda.hhs.gov]
Sent: Thursday, May 03, 2012 9:36 AM
To: 'Sharon Stancliff'; Steven M. Marcus….
Cc: Reuter, Nicholas (SAMHSA); …..
Subject: RE: Naloxone shortages and oxycodone in heroin abusers
It is helpful to FDA's monitoring efforts to receive first-hand reports of drug shortage experiences from all along the prescription drug distribution continuum. The web page with instructions is here
http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm142398.htm
You received this message because you are subscribed to the Google Groups "Naloxone & Overdose Prevention Education Working Group" group.
To post to this group, send email to NOPE_WG@googlegroups.com.
To unsubscribe from this group, send email to NOPE_WG+unsubscribe@googlegroups.com.
For more options, visit this group at http://groups.google.com/group/NOPE_WG?hl=en.
--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
WARNING: E-mail sent over the Internet is not secure. Information sent by e-mail may not remain confidential.
DISCLAIMER: This e-mail is intended only for the individual to whom it is addressed. It may be used only in accordance with applicable laws. If you received this e-mail by mistake, notify the sender and destroy the e-mail
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network
No comments:
Post a Comment